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In somatic cells, the tetraspanins CD81 and CD9 associate with each other, with additional tetraspanins and with non-tetraspanin molecules to
form proteolipidic complexes. Here we show that CD81 is expressed on the surface of oocytes where it associates with tetraspanin-enriched
membrane structures. A major CD9 and CD81 partner, CD9P-1, is also expressed by oocytes. Deletion of CD81 gene in mice results in a 40%
reduction of female fertility. In vitro insemination indicated that this infertility is due to a deficiency of oocytes to fuse with sperm. While the fertility
of CD9/mice is severely but not completely impaired, double knock-out CD9/CD81/mice were completely infertile indicating that CD9 and
CD81 play complementary roles in sperm–egg fusion. Finally, a fraction of CD9 was transferred from CD81/ oocytes to sperm present in the
perivitelline space indicating that the defect of fusion of CD81/ oocytes does not result from an impaired initial gamete interaction.
D 2005 Elsevier Inc. All rights reserved.Keywords: Infertility; Oocyte; Sperm; Fusion; CD81; CD9; TetraspaninIntroduction
The molecular basis of mammalian sperm–egg fusion is still
poorly understood. Several egg surface proteins have been
implicated in this process but few have been confirmed by gene-
targeting experiments (Evans, 2002; Stein et al., 2004). One
group of egg surface proteins implicated is the GPI-anchored
proteins. Indeed, treatment of mouse eggs with PI-PLC caused a
strong reduction of sperm–egg fusion (Coonrod et al., 1999).
Moreover, mice with oocyte-specific KO of GPI-anchored
proteins were recently demonstrated to be infertile, and oocytes
collected in these mice were severely deficient in their ability to
fuse with sperm in vitro (Alfieri et al., 2003).
The only surface egg protein that was shown to be essential
for fusion by gene KO is CD9. Indeed, CD9/ females have a
severe reduction of fertility, and CD9/ oocytes failed to fuse in0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.11.031
Abbreviations: ZP, zona pellucida; LED, large extracellular domain; KO,
knock-out.
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E-mail address: erubin@vjf.inserm.fr (E. Rubinstein).vitro (Le Naour et al., 2000; Miyado et al., 2000; Kaji et al.,
2000). Additionally, several CD9 mAbs were demonstrated to
inhibit the fusion process in vitro (Chen et al., 1999; Le Naour et
al., 2000). CD9 is a member of the tetraspanin superfamily that
comprises 32 members in human. Tetraspanins have 2 short N
and C intracellular terminal tails and 4 transmembrane domains
separating 2 extracellular domains of unequal size (Boucheix
and Rubinstein, 2001; Hemler, 2003; Levy and Shoham, 2005).
An isolated form of the largest of these extracellular domains
was able to partially inhibit fusion when preincubated with eggs,
not with sperm, indicating that somehow CD9 may function in
cis on the oocyte surface, possibly by interacting with another
surface protein (Zhu et al., 2002).
Tetraspanins have been implicated in various biological
processes such as cell adhesion, migration, co-stimulation,
signal transduction, and differentiation (reviewed in Boucheix
and Rubinstein, 2001; Hemler, 2003; Levy and Shoham,
2005). A major characteristic of tetraspanins is their ability to
interact with each other and with a large number of other
surface proteins, thus building an extensive network of
molecular interactions, the tetraspanin web. In a current
model, each tetraspanin interacts directly with a limited90 (2006) 351 – 358
www.e
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partner is a protein that interact with this tetraspanin under
conditions in which no tetraspanin to tetraspanin interaction is
observed), that they connect to other tetraspanins through
tetraspanin/tetraspanin interactions. This second level of
interaction is thought to occur in discrete microdomains
different from the GPI-anchored proteins-enriched microdo-
mains or rafts (Boucheix and Rubinstein, 2001; Hemler,
2003; Levy and Shoham, 2005). Two major molecular
partners have been identified for CD9, CD9P-1 and EWI-2
(Charrin et al., 2001, 2003; Stipp et al., 2001a,b; Clark et al.,
2001). They belong to a sub-family of proteins with Ig
domains, and it is not known whether they are expressed by
the oocyte. Among the molecules associated with tetraspa-
nins, a subset of integrins are molecular partner of the
tetraspanin CD151 (Yauch et al., 1998; Serru et al., 1999;
Fitter et al., 1999). Integrins that are expressed on the oocyte
surface include a6h1, which was shown to associate with
CD9 in the egg (Miyado et al., 2000). The integrin a6h1 has
long been considered to play a major role in sperm egg fusion
by its ability to interact with proteins of the ADAM family
expressed on the sperm, but this model was called into
question after it was demonstrated that oocytes lacking either
this integrin or possibly all h1 integrins could fuse with
sperm (Miller et al., 2000; He et al., 2003).
CD9 is not the only tetraspanin expressed by oocytes.
Human oocytes additionally express CD81 and CD151 (Ziyyat
et al., in press), while the expression of CD81 on mouse eggs
has been demonstrated (Takahashi et al., 2001). mAb to CD81
were shown to partially inhibit binding and fusion of sperm to
the egg (Takahashi et al., 2001). Moreover, overexpression of
CD81, following injection of mRNA in the eggs, could restore
partially the ability of CD9/ eggs to fuse with sperm (Kaji et
al., 2002). It is however not known whether endogenous CD81
plays a role in sperm–egg fusion.
The aim of this work was to evaluate the extent of fertility
impairment linked to the absence of CD81 and its relation with
CD9 infertility. For that purpose, we compared CD81/ mice
with CD9/ mice and double knockout mice.Materials and methods
Animals
C57BL/6 CD81/ (Maecker and Levy, 1997) and CD9/ (Le Naour et al.,
2000) mice were bred at the animal facility Lavoisier of Institute Andre´ Lwoff
(Villejuif, France). They were bred as heterozygotes, giving rise to knockout and
WT littermates. The animals were genotyped as previously described (Maecker
and Levy, 1997; LeNaour et al., 2000). Double knockout CD9/CD81/mice
were obtained by successive crossings of the 2 strains. Six- to 20-week-old mice
(age and sex matched) were used in all experiments. All animal protocols were
approved by the local Committee on Animal Welfare.
Preparation of oocytes
For natural ovulation studies, mice were mated at 8 p.m. and examined the
next morning for the presence of a plug. Females with plugs were sacrificed by
cervical dislocation. For in vitro fertilization experiments, they were super-
ovulated by intraperitoneal injections of 5 IU PMSG (Folligon, Intervet,France) and 5 IU hCG (Chorulon, Intervet, France) 48 h apart. Fifteen to 16
h after hCG injection, the animals were sacrificed. Cumulus–oocyte complexes
were collected by tearing the oviductal ampulla. Cumulus oophorus cells were
removed by hyaluronidase (type IVs, 300 Ag/ml, Sigma, St. Louis, MO)
treatment and oocytes were examined by phase contrast microscopy. For in
vitro fusion experiments with ZP-free oocytes, oocytes were transferred to a
HEPES-buffered culture CZB medium (Chatot et al., 1989). The zona was
removed by exposing the embryos to acid Tyrode’s solution (pH 2.1–2.5) for a
few seconds followed by immediate repeated rinsing in CZB medium.
Sperm preparation
Spermatozoa were collected after squeezing two caudae epididymis in wells
with 500 Al Whittingham’s medium supplemented with 30 mg/ml BSA under
mineral oil (Whittingham, 1971). Spermatozoa were incubated at 37-C in 5%
CO2 for 20 min. The sperm at the periphery of the wells were carefully
transferred to another well with the same medium. The plate was placed again
in the CO2 incubator and the sperm are counted in a Malassez count slide.
Oocyte DNA-tubulin labeling for meiosis stage assessment
Oocytes were fixed (Kubiak et al., 1992) and incubated with the anti-tubulin
mAb YL1/2 (Serotec, Oxford, UK), followed by fluorescein isothiocyanate
FITC-labeled goat F(ab)2 antibody to mouse and 1 Ag/ml propidium iodide. The
oocytes were then observed under a fluorescence microscope. Oocytes blocked
in metaphase of meiosis II were recognized by the presence of a metaphase
spindle and a first polar body containing residual DNA-tubulin material.
Progression to telophase and extrusion of a second polar body could be observed
following resumption of meiosis (Le Naour et al., 2000).
Sperm–egg fusion assay and in vitro fertilization
ZP free mature eggs were incubated for 10 min with 1 Ag/ml Hoechst
33342 in Whittingham medium supplemented with 30 mg/ml BSA (Sigma, St.
Louis, MO) followed by 5 washings of 5 min. in M16 medium. Oocytes were
then added to wells containing 105 sperm in 500 Al Whittingham-BSA medium
and incubated at 37-C 5% CO2 for 90 min. We considered as fused the
spermatozoa with Hoechst-stained nuclei (Conover and Gwatkin, 1988).
Usually, the sperm DNA was already decondensed and oocytes had resumed
meiosis. Alternatively inseminated ZP free eggs were kept at 37-C and 5%
CO2 for 24 h and the number of two-cell embryos were determined.
mAbs and fluorescence staining of eggs
Oocytes were fixed by transfer into a drop of paraformaldehyde at 4% in
PBS–BSA 1% for 30 min at room temperature. After washing, they were
stained with 20 Ag/ml rat primary mAb for 1 h and with Alexa 488-labeled goat
anti-rat IgG (10 Ag/ml) antibody for 1 h. The eggs were examined with a Leica
DMR fluorescence microscope equipped with a camera. For confocal
microscopy, the eggs were stained with an Alexa 488-coupled CD9 mAb.
The eggs were deposited in a small drop of medium in a labteck coverslip and
covered under mineral oil. Confocal analysis of CD9 expression was performed
with a TCS SP2 confocal microscope (Leica, Wetzlar, Germany), using a 63
objective. About 100 sections were collected and superimposed using the
maximum projection function of the LCS software (Leica). The mAbs used in
this study were 4.1F12 (CD9, (Le Naour et al., 2000)), MT81 and MT81w
(CD81, submitted for publication), EAT-1 (CD81, (Maecker et al., 2000)) and
8G1 (CD9P-1, submitted for publication).Results
Reduced fertility of CD81/ females
The fertility of CD81/ mice was reduced. Reduced
fertility was not apparent in these mice when originally derived
Table 2



















5 10.2 T 1.3 78 (51) 22
CD9+/+
CD81/
7 8.4 T 1.8 10 (40) 90
CD9/
CD81+/+
4 8 T 1.4 0 (32) 100
CD9/
CD81/
4 7.8 T 2.2 0 (23) 100
Eggs were collected the day after mating and stained with propidium iodide and
a mAb to tubulin to determine the meiotic stage.
a Values are the mean T SEM.
b The number in parenthesis indicates the number of oocytes examined.
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noticed after the 4–5th backcrossing both onto the C57BL/6
and the BALB/c backgrounds (Deng and Levy, unpublished
observations). This deficiency was not due to the male as
normal fertility was observed when CD81/ males were
mated with wild-type or heterozygous females. We have
previously shown that CD9/ male had a normal fertility.
CD9/ CD81/ males were also normally fertile (data not
shown).
Only ¨60% CD81/ females produced litters after being
maintained in the presence of fertile wild-type males for up to 2
months. This rate was similar to that of CD9/ animals.
However, the litter size was normal for CD81/ mice, while it
was reduced to 1.5 T 0.8 for CD9/ females. In addition, the
delay between mating and the beginning of a successful
pregnancy was also normal for CD81/ mice while it was
increased from 5.9 T 3.4 days to 19 T 17 days for CD9/ mice.
The important role of CD81 in female fertility was especially
apparent using CD9/ CD81/ females for which no visible
pregnancy or birth was observed (Table 1). In contrast, the
fertility of CD9+/ or CD81+/ females and doubly heterozy-
gous CD9+/ CD81+/ females was normal.
The initial postnatal mortality rate was high for pups
produced by CD81/ females (31%), as compared to less
than 2% for wild type females. A decreased viability of
CD81/ animals beyond the first hours of life has been
reported previously (Kelic et al., 2001).
Normal mating and ovulation but defective in vivo fertilization
of CD81/, CD9/ and double KO CD9/ CD81/
females
No difference in the frequency of vaginal plugs was
observed between the different groups of animals indicating
that CD81/ and double KO females had a normal mating
behavior (data not shown), similar to what was described for
CD9/ females (Le Naour et al., 2000). The infertility was
also not due to the absence of sperm at the site of fertilization,
as shown by the presence of numerous sperm in the oviduct.
Also, there was no abnormality of the ovaries as determined by
histological examination of 6-week-old animals (data notTable 1
















(% at 48 h)
WT 10 100 5.9 T 3.4 7 T 2.6 0
CD9/ 10 60 19 T 17 1.5 T 0.8 55
CD81/ 16 62 4 T 6.5 6 T 1.4 31
CD9/
CD81/
6 0 n.a. n.a. n.a.
CD9+/
CD81+/
11 100 3.9 T 4.8 8.7 T 2.6 0
Mice were continuously mated until pregnancy or for a period of at least 60
days.
a Values are the mean T SEM; n.a. not applicable.shown). Natural ovulation of CD81/ and double KO
CD81/ CD9/ females was normal as the number of
oocytes ovulated by each group of animals was similar (Table
2) and all were apparently normal. However precise assessment
of the meiotic stage by tubulin/propidium iodide labeling of
oocytes collected at day 0.5 after mating showed resumption of
meiosis in 78% of oocytes collected in wild type females
whereas it was reduced to 10% in CD81/ females and null in
CD9/ or double knockout mice. We never observed a sperm
nucleus in the cytoplasm of CD81/ (or CD9/) eggs that
had not resumed meiosis, strongly suggesting that fusion had
not occurred. Like the oocytes recovered from mated CD9/
females at day 0.5, those recovered from CD81/ and double
KO mice had frequently several highly mobile sperm in the
perivitelline space suggesting that there was no preclusion of
multiple sperm from traversing the zona and entering the
perivitelline space. This block occurs if a sperm fuses with the
egg (Table 2).
Altered fusion of CD81/ eggs with WT sperm
The presence of several sperm in the perivitelline space and
the lack of meiosis completion suggested that CD81/ and
double KO eggs were defective in their ability to fuse with
sperm. To check this hypothesis, and eliminate a defect in
events subsequent to fusion, in vitro fertilization experiments
using the Hoechst dye transfer test were performed (Conover
and Gwatkin, 1988). In these experiments, ZP-free oocytes are
incubated with Hoechst 33342 before washing. The dye is
retained in the cytoplasm, and labels the sperm DNA only after
fusion. This test also allows the observation of sperm DNA
decondensation and resumption of meiosis. Fusion was
observed in more than 90% of wild type oocytes after 90
min insemination. In contrast, no fusion was observed in
CD9/ oocytes, and only 3% of CD81/ oocytes fused with
a capacitated sperm. This shows that CD81, like CD9, is
involved in sperm–egg fusion. To examine whether fusion
could occur with a delay, we counted the number of two-cell
embryos 24 h after fertilization. While 85% of WT eggs were
Fig. 2. Effect of CD9 and CD81 mAbs on sperm–egg fusion. After ZP
removal, WT oocytes were incubated with capacitated sperm for 24 h, in the
presence of CD9, CD81 or control mAb. The number of two-cell embryos was
determined.
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CD9/ eggs produced a two-cell embryo. Five out of 44
CD81/ eggs tested (11%, 4 females) produced two-cell
embryos (Fig. 1B).
CD81 mAb do not prevent sperm–egg fusion
To our knowledge, all CD9 mAb tested so far strongly
inhibit fusion (KMC8, JF9, 4.1F12) (Le Naour et al., 2000;
Chen et al., 1999; Miller et al., 2000). In a previous report, the
CD81 mAb 2F7 was found to block fusion by only 17%, while
the CD81 mAb Eat-1 blocked fusion and sperm–egg binding
by 40% (Takahashi et al., 2001). We tested whether other
CD81 mAb could block the fusion process. In one set of
experiments, the effect of a hamster mAb Eat-1 and of a CD9
mAb 4.1F12 were tested on the fusion of ZP-free eggs with
sperm. As shown in Fig. 2, Eat-1 mAb (100 Ag/ml) did not
have any effect on fusion, while the CD9 mAb 4.1F12
inhibited fusion by 80%. In another set of experiments, a
newly generated CD81 mAb, MT81 (200 Ag/ml), also failed to
inhibit the fusion of zona–intact oocytes with sperm (data not
shown). The two CD81 mAb used in this study are functional
since they inhibit the invasion of hepatocytes by the rodent
malaria parasite Plasmodium yoelii (Silvie et al., 2003) (dataFig. 1. In vitro fertilization assay. (A) After ZP removal, oocytes collected in
mice lacking CD9 or CD81 were loaded with Hoechst 33342 and incubated
with capacitated sperm for 90 min. Fertilized eggs were recognized by the
presence of Hoechst-stained sperm nuclei. (B) The oocytes with the indicated
genotype were incubated with sperm with 24 h, and the number of two-cell
embryos was determined.not shown). Thus, in contrast to CD9, most CD81 mAb have a
poor or no effect on sperm–egg fusion. Because CD9 and
CD81 are closely related, and CD9 and CD81 mAb often
produce similar effects (Boucheix and Rubinstein, 2001), this
may reveal differences in the mechanism by which CD9 and
CD81 participate in sperm–egg fusion.
Expression of CD9, CD81 and CD9P-1 on mouse oocytes
To our knowledge, all anti mouse CD81 mAbs have been
raised in hamster, while all anti-mouse CD9 mAb have been
raised in rat. We have generated 2 rat anti-mouse CD81 mAb
(submitted for publication). MT81 is directed against the bulk
of CD81 molecules, and stains certain cell lines with the same
intensity as the CD9 mAb, in contrast to previously described
anti-CD81 hamster mAb such as Eat-1 and Eat-2 (data not
shown). It is therefore a better tool to compare the expression
levels of CD9 and CD81 by indirect immunofluorescence. The
staining by the anti-CD9 mAb on the egg surface was much
brighter than the staining by the anti-CD81 mAb, subsequently,
detection of CD81 required fourfold exposure time by
comparison to CD9 (Fig. 3). It became recently evident that
certain anti-tetraspanin mAb were directed against sub-popula-
tions of the target tetraspanin (Serru et al., 1999; Gutierrez-
Lopez et al., 2003). The other CD81 mAb, MT81w, recognizes
CD81 only in association with other tetraspanins (submitted for
publication) and therefore detection by this mAb indicates the
localization of CD81 in tetraspanin-enriched microdomains. As
shown in Fig. 3, the staining of eggs by the 2 CD81 mAb were
very similar indicating that in the egg, the bulk of CD81 is in
tetraspanin-enriched microdomains.
Two major molecular partners of CD9 and CD81 have
recently been identified, CD9P-1 and EWI-2. As seen in Fig. 3,
the anti-CD9P-1 mAb 8G1 stained the oocyte, indicating
expression of CD9P-1. CD9P-1 expression was also observed
on oocytes in the ovary (data not shown).
Sperm failing to fuse with zona-intact CD81/ eggs acquire
CD9
We have recently demonstrated that CD9 was subjected to a
major redistribution in the course of fertilization (Ziyyat et al.,
Fig. 4. Transfer of CD9 from CD81/ oocytes to sperm head. CD81/ or
CD9/ mouse intact oocytes were inseminated with wild-type sperms. After
3-h incubation, the eggs were fixed, labeled with the CD9 mAb 4.1F12 and
analyzed by confocal microscopy as described in Materials and methods.
Transmission images are also shown. (A, B): a non-inseminated CD81/
egg; (C, D): an inseminated CD81/ egg; (E–G): a single section showing
that a sperm in the perivitelline space is labeled with the CD9 mAb. G is a
combination of panels E and F. (H, I): an inseminated CD9/ egg. Arrows
indicate sperm heads. They are not all visible on the transmission images.
Scale bar, 40 Am.
Fig. 3. Expression of CD9, CD81 and CD9P-1 on oocytes. After ZP removal,
WT oocytes were stained with mAbs to CD9 (4.1F12), CD81 (MT81 and
MT81w) and CD9P-1 (8G1). They were examined by fluorescence microscopy
and images were taken using a high-resolution camera. The exposition times for
CD9, CD81 and CD9P-1 labeling were 1/4 s, 1 s and 2 s, respectively. The
control is shown after a 2-s exposure. Scale bar, 20 Am.
E. Rubinstein et al. / Developmental Biology 290 (2006) 351–358 355in press). We thus examined the localization of CD9 in non-
inseminated and inseminated CD81/ zona-intact oocytes.
After 3 h, the eggs were fixed, labelled with the CD9 mAb, and
analyzed by confocal microscopy. As seen in Fig. 4A, the
distribution of CD9 in CD81/ oocytes was finely punctuate
in the microvillar region, probably reflecting a concentration on
microvilli (Kaji et al., 2000). This is very similar to the
distribution of CD9 in WT oocytes (Ziyyat et al., in press; Kaji
et al., 2000). The distribution of CD9 in inseminated CD81/
oocytes was still finely punctate but more heterogeneous (Fig.
4C). It is different from the distribution observed in
inseminated WT eggs where CD9 formed large patches upon
fertilization (Ziyyat et al., in press). As stated earlier, most
CD81/ were not fertilized and several sperm were frequently
observed in the perivitelline space. Surprisingly, the sperm
heads were strongly labeled by the CD9 mAb (Fig. 4C). The
intensity of staining exceeds that of the egg membrane. An
analysis of sperm in more equatorial sections (Figs. 4E–G),
indicated that the labeling was indeed on the sperm head. No
significant labeling could be observed on WT sperm present in
the perivitelline space of CD9/ eggs (Fig. 4H), indicating
that 1, the labeling is specific and 2, this CD9 fraction present
on sperm was transferred from the egg.
Discussion
CD9 is the only oocyte surface molecule whose role in
sperm–egg fusion is clearly established. In this study we
investigated the role of another tetraspanin present on eggs,
CD81. We have demonstrated that the lack of CD81 produces adefect in fertility of the mouse female. This defect is actually
linked to the absence of CD81 as transgenic expression of
human CD81 in CD81/ mice (Masciopinto et al., 2002)
restored the fertility (S. Levy, unpublished data). Like CD9,
CD81 plays a role in sperm–egg fusion as demonstrated by in
vitro insemination. The defect of CD81/ mice only became
evident when mice were backcrossed onto homogenous
background. Moreover, it was milder than that of CD9/
mice as the overall reduction in fertility of CD81/ mice was
40%. In CD9/ mice, considering that a mean of 5 ovulatory
cycles was necessary to produce 1.5 pups in 60% of the
animals, the reduction of fertility is above 95%. In addition, a
residual fertilization could be observed in vitro using oocytes
from CD81/ females whereas no fusion was observed with
oocytes from CD9/ females. Moreover, mice lacking both
tetraspanins were completely infertile indicating that both
tetraspanins act in concert for an effective fertilization.
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having 45% identity to each other. The level of identity in the
tetraspanin superfamily ranges from 7 to 57% identity
(Boucheix and Rubinstein, 2001). Second, their association
in tetraspanin-enriched microdomains is more stable than the
association with any other tetraspanin studied (Charrin et al.,
2002). Third, they share the ability to interact directly
(‘‘primary interactions’’) with at least two tetraspanin partners,
CD9P-1 and EWI-2. These data raise the hypothesis that the
roles of CD9 and CD81 might be completely redundant for
certain functions. If this hypothesis was true for sperm–egg
fusion, the ability of oocytes to fuse would be directly linked to
the total level of expression of CD9 and CD81. Because
oocytes express less CD81 than CD9, as determined by indirect
immunofluorescence, the deletion of one allele of CD9 has a
greater impact on the total level of CD9 plus CD81 than the
deletion of one CD81 allele, and thus should have a greater
impact on fertility. The data presented here show that this is not
the case. Indeed, CD9+/ CD81+/ mice, that have a normal
fertility (and oocytes collected in these mice have a normal
ability to fuse in vitro), express a smaller quantity of CD9 plus
CD81 than CD9+/+, CD81/ mice, that have a reduced
fertility. A previous study has also shown that, following
microinjection of mRNA, CD81 was less efficient in restoring
the fusion ability of CD9/ eggs (Kaji et al., 2002). This result
indicates that CD81 cannot completely substitute for CD9,
even, after overexpression. Altogether, these data suggest that
CD9 and CD81 play complementary roles in sperm–egg
fusion and cannot substitute for each other in this process.
The moderate effect of CD81 deletion on overall fertility
contrasts with the strongly reduced number of fertilized eggs
collected at day 0.5. In many of the eggs collected from mated
CD81/ mice, several sperm were present in the perivitelline
space, but only 10% of eggs had resumed meiosis II. The
simplest explanation for this discrepancy is that the delay
necessary for fusion after ZP crossing by sperm is increased in
CD81/ oocytes. This may explain why the defect of CD81/
oocytes is amplified in vitro, with only 3% of the eggs being
fertilized after 90 min. Only a moderate increase of fertilization
rate that reached 10% was observed when eggs were examined
after 24 h but it is well known that the gametes loose their ability
to fuse over time and this may be amplified in vitro. The average
delay between ZP crossing and fusion in CD81/ eggs may be
prolonged beyond the period in which gametes remain
competent for fusion.
At least 2 interpretations of the role of CD81 in gamete
fusion may be proposed. First, it may contribute to the
formation of a tetraspanin web on oocytes. In this regard,
staining of oocytes with mAb MT81w which recognizes CD81
only in the context of tetraspanin-enriched microdomains
(submitted for publication) indicated that the bulk of CD81
molecules were localized in these domains. If this hypothesis
was true, altered expression of other tetraspanins expressed by
oocytes should produce similar defects in fusion. PCR-SAGE
analysis and immunostaining have demonstrated that CD151
is expressed by human oocytes (Neilson et al., 2000) (and data
not shown). However, CD151 KO females have no fertilitydefect (Wright et al., 2004). Also, as stated earlier, the fact that
CD9+/ CD81+/ mice have a normal fertility does not support
the hypothesis that CD81 deficiency causes a global disorga-
nization of the tetraspanin web. Alternatively, CD81 may
associate with a partner molecule that plays an important role
in the fusion process, and functionally regulate this partner,
possibly in the context of the tetraspanin web. A similar
hypothesis has been raised for CD9 (Le Naour et al., 2000;
Zhu et al., 2002). Direct interactions of tetraspanins with
partner molecules have so far been shown to involve the LED
of tetraspanins (Stipp et al., 2003; Charrin et al., 2003).
Consistent with a role of CD9 LED, a CD9 mutant with 3
adjacent mutations in the most variable region of the LED was
not competent for fusion, and isolated CD9 LED could inhibit
fusion when preincubated with oocytes, suggesting a role in
cis for CD9 (Zhu et al., 2002). Recently, it was demonstrated
that isolated CD81 LED could also inhibit the fusion of
gametes, indicating a role for CD81 LED and possibly CD81-
associated molecules (Higginbottom et al., 2003). CD9 and
CD81 have two common partners, CD9P-1 and EWI-2, which
belong to a new subfamily of proteins with Ig domains
(Charrin et al., 2001, 2003; Stipp et al., 2001a,b; Clark et al.,
2001). We have demonstrated for the first time that CD9P-1 is
expressed both on freshly ovulated oocytes, and in the ovary.
These data contrast with a previous study that failed to
demonstrate the expression of CD9P-1/FPRP on the oocytes
of rat ovaries (Orlicky et al., 1992). This discrepancy may be
due to the use of a polyclonal antibody in this other study. It
will be of special interest to determine whether CD9P-1 plays
a role in sperm–egg fusion. In preliminary experiments, the
mAb 8G1 directed against this molecule failed to inhibit
fusion.
How CD9 and CD81 participate to sperm–egg fusion is
unknown. The membrane fusion process can be divided into 2
successive events. The first step consists in an attachment of the
two membranes and is achieved through protein–protein
interaction. This step is followed by membrane apposition and
then lipid mixing (Jahn et al., 2003; Chen and Olson, 2005; Stein
et al., 2004). Sperm cells bind equally well to WT and CD9/
oocytes after ZP removal (Le Naour et al., 2000; Miyado et al.,
2000; Kaji et al., 2000). However, the binding of sperm to ZP-
free oocytes may not be physiological for at least two reasons.
First, most sperm bound to ZP-free oocytes cannot progress to
fusion (Talbot et al., 2003). Second, the sperm accumulating into
the perivitelline space of CD9/ or CD81/ oocytes do not
stably bind to the oocyte plasma membrane. Instead, they move
actively and attach transiently to the oocyte surface, sometimes
triggering a rolling of the oocyte on itself (data not shown). Thus
these data did not discriminate between a role of CD9 or CD81
in attachment or in fusion. In this study we have shown that a
fraction of CD9 is transferred from CD81/ oocyte to the
sperm heads. Two hypotheses can be raised to explain this
transfer. First, fusion between egg and sperm membranes may
have been initiated but aborted before the nucleus was released
into the egg cytoplasm, yielding some membrane exchange.
Alternatively, the sperm may interact firmly with the egg in a
way that does not lead to fusion. As stated in the results section,
E. Rubinstein et al. / Developmental Biology 290 (2006) 351–358 357the sperm is highly motile in the perivitelline space of CD81/
(and CD9/) eggs, making frequent contacts with the oocyte
and sometimes triggering a rolling of the oocyte on itself. The
sperm movements may therefore be so strong that the sperm
detach from the egg pulling out plasma membrane fragments. In
this hypothesis, the concentration of CD9 on sperm would
increase with the number of contacts made, which is consistent
with the sperm head labeling being much higher than the egg
surface labeling. This hypothesis is also consistent with the
altered CD9 labeling of inseminated CD81/ eggs. Transfer of
membrane fragments between two cells has already been
described especially between antigen-presenting cells and
lymphoid T cells (Hudrisier and Bongrand, 2002). In any case,
our data strongly suggest that sperm binds to CD81/ oocytes,
in a way that does not lead to effective fusion.
Cell–cell fusion occurs in a variety of physiological and
pathological situations, and CD9 and CD81 may play a general
role in this phenomenon. This role was initially put in evidence
by the demonstration that CD81 and CD82 mAb reduced the
formation of syncytium by the retrovirus HTLV-1 (Imai et al.,
1992). Then, CD9 mAb were demonstrated to inhibit the
syncytium formation by canine distemper virus, a virus related
to measles virus (Schmid et al., 2000). Both CD9 and CD81
mAb were shown to inhibit the fusion of myoblasts, and
overexpression of CD9 in myoblast-derived sarcoma cells
increases syncytium formation (Tachibana and Hemler, 1999).
It was also recently reported that CD9 and CD81 could
function as inhibitors of the fusion of mononuclear phagocytes
in several infectious pathologies (Takeda et al., 2003).
Interestingly, while enhanced cell fusion was observed after
in vitro or vivo stimulation in the absence of CD9 or CD81,
spontaneous multinucleated giant cell formation was detected
in the lung only when these two tetraspanins were lacking. The
mechanism by which tetraspanins interfere with fusion events
is still poorly understood. The recent identification of Izumo,
an Ig-domain molecule present on sperm that is essential for
sperm egg fusion (Inoue et al., 2005) will help to better
characterize this process. It will be of special interest to
determine whether this molecule can interact with tetraspanins
or tetraspanin-associated molecules.Acknowledgments
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